Home Healthcare Pharmaceuticals Antithrombin Market

Antithrombin Market Size, Share & Trends Analysis Report By Source (Human, Recombinant Goat Milk), By Dosage Form (Lyophilized Powder, Liquid Form), By Application (Therapeutics, Research, Diagnostics, Others), By End User (Hospitals, Specialty Clinics, Academic & Research Institutes, Diagnostic Laboratories, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SR7122DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Antithrombin Market, By Source 2022-2034 (USD MILLION/ Units)
    1. Human
    2. Recombinant Goat Milk
  2. Antithrombin Market, By Dosage Form 2022-2034 (USD MILLION/ Units)
    1. Lyophilized Powder
    2. Liquid Form
  3. Antithrombin Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Therapeutics
    2. Research
    3. Diagnostics
    4. Others
  4. Antithrombin Market, By End User 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Specialty Clinics
    3. Academic & Research Institutes
    4. Diagnostic Laboratories
    5. Others
  5. Regional Antithrombin Market
    1. North America
      1. North America Antithrombin Market By Source 2022-2034 (USD MILLION/ Units)
        1. Human
        2. Recombinant Goat Milk
      2. North America Antithrombin Market By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Lyophilized Powder
        2. Liquid Form
      3. North America Antithrombin Market By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
        3. Diagnostics
        4. Others
      4. North America Antithrombin Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Academic & Research Institutes
        4. Diagnostic Laboratories
        5. Others
      5. U.S.
        1. Human
        2. Recombinant Goat Milk
        3. Lyophilized Powder
        4. Liquid Form
        5. Therapeutics
        6. Research
        7. Diagnostics
        8. Others
        9. Hospitals
        10. Specialty Clinics
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
        13. Others
      6. Canada
        1. Human
        2. Recombinant Goat Milk
        3. Lyophilized Powder
        4. Liquid Form
        5. Therapeutics
        6. Research
        7. Diagnostics
        8. Others
        9. Hospitals
        10. Specialty Clinics
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
        13. Others
    2. Europe
      1. Europe Antithrombin Market By Source 2022-2034 (USD MILLION/ Units)
        1. Human
        2. Recombinant Goat Milk
      2. Europe Antithrombin Market By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Lyophilized Powder
        2. Liquid Form
      3. Europe Antithrombin Market By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
        3. Diagnostics
        4. Others
      4. Europe Antithrombin Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Academic & Research Institutes
        4. Diagnostic Laboratories
        5. Others
      5. U.K.
        1. Human
        2. Recombinant Goat Milk
        3. Lyophilized Powder
        4. Liquid Form
        5. Therapeutics
        6. Research
        7. Diagnostics
        8. Others
        9. Hospitals
        10. Specialty Clinics
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
        13. Others
      6. Germany
        1. Human
        2. Recombinant Goat Milk
        3. Lyophilized Powder
        4. Liquid Form
        5. Therapeutics
        6. Research
        7. Diagnostics
        8. Others
        9. Hospitals
        10. Specialty Clinics
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
        13. Others
      7. France
        1. Human
        2. Recombinant Goat Milk
        3. Lyophilized Powder
        4. Liquid Form
        5. Therapeutics
        6. Research
        7. Diagnostics
        8. Others
        9. Hospitals
        10. Specialty Clinics
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
        13. Others
      8. Spain
        1. Human
        2. Recombinant Goat Milk
        3. Lyophilized Powder
        4. Liquid Form
        5. Therapeutics
        6. Research
        7. Diagnostics
        8. Others
        9. Hospitals
        10. Specialty Clinics
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
        13. Others
      9. Italy
        1. Human
        2. Recombinant Goat Milk
        3. Lyophilized Powder
        4. Liquid Form
        5. Therapeutics
        6. Research
        7. Diagnostics
        8. Others
        9. Hospitals
        10. Specialty Clinics
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
        13. Others
      10. Russia
        1. Human
        2. Recombinant Goat Milk
        3. Lyophilized Powder
        4. Liquid Form
        5. Therapeutics
        6. Research
        7. Diagnostics
        8. Others
        9. Hospitals
        10. Specialty Clinics
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
        13. Others
      11. Nordic
        1. Human
        2. Recombinant Goat Milk
        3. Lyophilized Powder
        4. Liquid Form
        5. Therapeutics
        6. Research
        7. Diagnostics
        8. Others
        9. Hospitals
        10. Specialty Clinics
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
        13. Others
      12. Benelux
        1. Human
        2. Recombinant Goat Milk
        3. Lyophilized Powder
        4. Liquid Form
        5. Therapeutics
        6. Research
        7. Diagnostics
        8. Others
        9. Hospitals
        10. Specialty Clinics
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
        13. Others
      13. Rest of Europe
        1. Human
        2. Recombinant Goat Milk
        3. Lyophilized Powder
        4. Liquid Form
        5. Therapeutics
        6. Research
        7. Diagnostics
        8. Others
        9. Hospitals
        10. Specialty Clinics
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
        13. Others
    3. APAC
      1. APAC Antithrombin Market By Source 2022-2034 (USD MILLION/ Units)
        1. Human
        2. Recombinant Goat Milk
      2. APAC Antithrombin Market By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Lyophilized Powder
        2. Liquid Form
      3. APAC Antithrombin Market By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
        3. Diagnostics
        4. Others
      4. APAC Antithrombin Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Academic & Research Institutes
        4. Diagnostic Laboratories
        5. Others
      5. China
        1. Human
        2. Recombinant Goat Milk
        3. Lyophilized Powder
        4. Liquid Form
        5. Therapeutics
        6. Research
        7. Diagnostics
        8. Others
        9. Hospitals
        10. Specialty Clinics
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
        13. Others
      6. Korea
        1. Human
        2. Recombinant Goat Milk
        3. Lyophilized Powder
        4. Liquid Form
        5. Therapeutics
        6. Research
        7. Diagnostics
        8. Others
        9. Hospitals
        10. Specialty Clinics
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
        13. Others
      7. Japan
        1. Human
        2. Recombinant Goat Milk
        3. Lyophilized Powder
        4. Liquid Form
        5. Therapeutics
        6. Research
        7. Diagnostics
        8. Others
        9. Hospitals
        10. Specialty Clinics
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
        13. Others
      8. India
        1. Human
        2. Recombinant Goat Milk
        3. Lyophilized Powder
        4. Liquid Form
        5. Therapeutics
        6. Research
        7. Diagnostics
        8. Others
        9. Hospitals
        10. Specialty Clinics
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
        13. Others
      9. Australia
        1. Human
        2. Recombinant Goat Milk
        3. Lyophilized Powder
        4. Liquid Form
        5. Therapeutics
        6. Research
        7. Diagnostics
        8. Others
        9. Hospitals
        10. Specialty Clinics
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
        13. Others
      10. Taiwan
        1. Human
        2. Recombinant Goat Milk
        3. Lyophilized Powder
        4. Liquid Form
        5. Therapeutics
        6. Research
        7. Diagnostics
        8. Others
        9. Hospitals
        10. Specialty Clinics
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
        13. Others
      11. South East Asia
        1. Human
        2. Recombinant Goat Milk
        3. Lyophilized Powder
        4. Liquid Form
        5. Therapeutics
        6. Research
        7. Diagnostics
        8. Others
        9. Hospitals
        10. Specialty Clinics
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
        13. Others
      12. Rest of Asia-Pacific
        1. Human
        2. Recombinant Goat Milk
        3. Lyophilized Powder
        4. Liquid Form
        5. Therapeutics
        6. Research
        7. Diagnostics
        8. Others
        9. Hospitals
        10. Specialty Clinics
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
        13. Others
    4. Middle East and Africa
      1. Middle East and Africa Antithrombin Market By Source 2022-2034 (USD MILLION/ Units)
        1. Human
        2. Recombinant Goat Milk
      2. Middle East and Africa Antithrombin Market By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Lyophilized Powder
        2. Liquid Form
      3. Middle East and Africa Antithrombin Market By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
        3. Diagnostics
        4. Others
      4. Middle East and Africa Antithrombin Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Academic & Research Institutes
        4. Diagnostic Laboratories
        5. Others
      5. UAE
        1. Human
        2. Recombinant Goat Milk
        3. Lyophilized Powder
        4. Liquid Form
        5. Therapeutics
        6. Research
        7. Diagnostics
        8. Others
        9. Hospitals
        10. Specialty Clinics
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
        13. Others
      6. Turkey
        1. Human
        2. Recombinant Goat Milk
        3. Lyophilized Powder
        4. Liquid Form
        5. Therapeutics
        6. Research
        7. Diagnostics
        8. Others
        9. Hospitals
        10. Specialty Clinics
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
        13. Others
      7. Saudi Arabia
        1. Human
        2. Recombinant Goat Milk
        3. Lyophilized Powder
        4. Liquid Form
        5. Therapeutics
        6. Research
        7. Diagnostics
        8. Others
        9. Hospitals
        10. Specialty Clinics
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
        13. Others
      8. South Africa
        1. Human
        2. Recombinant Goat Milk
        3. Lyophilized Powder
        4. Liquid Form
        5. Therapeutics
        6. Research
        7. Diagnostics
        8. Others
        9. Hospitals
        10. Specialty Clinics
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
        13. Others
      9. Egypt
        1. Human
        2. Recombinant Goat Milk
        3. Lyophilized Powder
        4. Liquid Form
        5. Therapeutics
        6. Research
        7. Diagnostics
        8. Others
        9. Hospitals
        10. Specialty Clinics
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
        13. Others
      10. Nigeria
        1. Human
        2. Recombinant Goat Milk
        3. Lyophilized Powder
        4. Liquid Form
        5. Therapeutics
        6. Research
        7. Diagnostics
        8. Others
        9. Hospitals
        10. Specialty Clinics
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
        13. Others
      11. Rest of MEA
        1. Human
        2. Recombinant Goat Milk
        3. Lyophilized Powder
        4. Liquid Form
        5. Therapeutics
        6. Research
        7. Diagnostics
        8. Others
        9. Hospitals
        10. Specialty Clinics
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
        13. Others
    5. LATAM
      1. LATAM Antithrombin Market By Source 2022-2034 (USD MILLION/ Units)
        1. Human
        2. Recombinant Goat Milk
      2. LATAM Antithrombin Market By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Lyophilized Powder
        2. Liquid Form
      3. LATAM Antithrombin Market By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
        3. Diagnostics
        4. Others
      4. LATAM Antithrombin Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Academic & Research Institutes
        4. Diagnostic Laboratories
        5. Others
      5. Brazil
        1. Human
        2. Recombinant Goat Milk
        3. Lyophilized Powder
        4. Liquid Form
        5. Therapeutics
        6. Research
        7. Diagnostics
        8. Others
        9. Hospitals
        10. Specialty Clinics
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
        13. Others
      6. Mexico
        1. Human
        2. Recombinant Goat Milk
        3. Lyophilized Powder
        4. Liquid Form
        5. Therapeutics
        6. Research
        7. Diagnostics
        8. Others
        9. Hospitals
        10. Specialty Clinics
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
        13. Others
      7. Argentina
        1. Human
        2. Recombinant Goat Milk
        3. Lyophilized Powder
        4. Liquid Form
        5. Therapeutics
        6. Research
        7. Diagnostics
        8. Others
        9. Hospitals
        10. Specialty Clinics
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
        13. Others
      8. Chile
        1. Human
        2. Recombinant Goat Milk
        3. Lyophilized Powder
        4. Liquid Form
        5. Therapeutics
        6. Research
        7. Diagnostics
        8. Others
        9. Hospitals
        10. Specialty Clinics
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
        13. Others
      9. Colombia
        1. Human
        2. Recombinant Goat Milk
        3. Lyophilized Powder
        4. Liquid Form
        5. Therapeutics
        6. Research
        7. Diagnostics
        8. Others
        9. Hospitals
        10. Specialty Clinics
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
        13. Others
      10. Rest of LATAM
        1. Human
        2. Recombinant Goat Milk
        3. Lyophilized Powder
        4. Liquid Form
        5. Therapeutics
        6. Research
        7. Diagnostics
        8. Others
        9. Hospitals
        10. Specialty Clinics
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
        13. Others
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.